Antibacterial tests of bismuth(III)-quinolone (ciprofloxacin, cf) compounds against Helicobacter pylori and some other bacteria. Crystal structure of (cfH2)2[Bi2Cl10]·4H2O

Journal of Inorganic Biochemistry

Volumn 71, Issue 1-2, 1998, Pages 53-60

  Turel, Iztok ^a   Golič, Ljubo ^a   Bukovec, Peter ^a   Gubina, Marija ^b  

^a UNIVERSITY OF LJUBLJANA   (Slovenia)

^b UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

Bismuth; Ciprofloxacin; Crystal structure; Helicobacter pylori; Quinolone

Indexed keywords

BISMUTH DERIVATIVE; CIPROFLOXACIN; QUINOLONE DERIVATIVE;

ANTIBACTERIAL ACTIVITY; ARTICLE; CRYSTAL STRUCTURE; DRUG STRUCTURE; HELICOBACTER PYLORI; NONHUMAN; STRUCTURE ANALYSIS;

ANTI-INFECTIVE AGENTS; BISMUTH; CIPROFLOXACIN; CRYSTALLOGRAPHY, X-RAY; ENTEROCOCCUS; FLUOROQUINOLONES; HELICOBACTER PYLORI; HYDROGEN BONDING; MICROBIAL SENSITIVITY TESTS; MODELS, MOLECULAR; ORGANOMETALLIC COMPOUNDS; STREPTOCOCCUS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0031689150     PISSN: 01620134     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0162-0134(98)10032-6     Document Type: Article

References (31)

1. J. Marshall, J.R. Warren, Lancet i (1984) 1311.
2. Rauws E.A.J., Tytgat G.N.J. Lancet. 335:1990;1233.
3. McNulty C.A.M., Dent J., Wise R. Antimicrob. Agents Chemother. 28:1985;837.
4. Y. Glupczynski, M. Labbe, A. Burette, M. Delmee, V. Avesani, C. Bruck, Lancet i (1987) 1096.
5. van der Linden B. Curr. Opin. Inf. Dis. 7:1994;577.
6. D.Y. Graham, Helicobacter pylori. Basic Mechanisms to Clinical Cure, Kluwer Academic Publishers, Boston, MA, 1994, pp. 531-537.
7. Goodwin C.S., Blake P., Blincow E. J. Antimicrob. Chemother. 17:1986;309.
8. Arias-Negrete S., Nieto-Gómez M., Anáya-Velasquez F., García-Nieto R.M., Mendoza-Díaz G. Rev. Soc. Quím. 37:1993;3.
9. Lecomte S., Baron M.H., Chenon M.T., Coupry C., Moreau N.J. Antimicrob. Agents Chemother. 38:1994;2810.
10. Ruiz M., Perelló L., Ortiz R., Castiñeiras A., Maichle-Mössmer C., Cantón E. J. Inorg. Biochem. 59:1995;801.
11. Gao F., Yang P., Xie J., Wang H. J. Inorg. Biochem. 60:1995;61.
12. Turel I., Leban I., Klintschar G., Bukovec N., Zalar S. J. Inorg. Biochem. 66:1997;77.
13. Turel I., Leban I., Bukovec N. J. Inorg. Biochem. 66:1997;241.
14. Turel I., Gruber K., Leban I., Bukovec N. J. Inorg. Biochem. 61:1996;197.
15. Enraf-Nonius, CAD-4 Software, version 5.0, Enraf-Nonius, Delft, The Netherlands, 1989.
16. S.R. Hall, H.D. Flack, J.M. Stewart (Eds.), Xtal 3.2, Reference Manual, Universities of Western Australia, Australia, Geneva, Switzerland, and Maryland, USA, 1992.
17. C.K. Johnson, ORTEP, Report ORNL-5138, Oak Ridge National Laboratory, Tennessee, USA (1976).
18. Turel I., Bukovec P., Quirós M. Int. J. Pharm. 152:1997;59.
19. Jarraya S., Ben Hassen R., Daoud A. Acta Crystallogr. C. 51:1995;2537.
20. Bigoli F., Lanfranchi M., Pellinghelli M.A. Inorg. Chim. Acta. 90:1984;215.
21. N.N. Greenwood, A. Earnshaw, Chemistry of the Elements, 2nd ed., Butterworth Heinemann, Oxford, 1997, pp. 547-600.
22. W.R. Reynolds, in: S.J. Lippard (Ed.), Prog. Inorg. Chem., vol. 12, Interscience, New York, 1970, p. 1.
23. Jones P.G., Henschel D., Weitze A., Blaschette A. Z. Anorg. Allg. Chem. 620:1994;1037.
24. Weitze A., Blaschette A., Henschel D., Jones P.G. Z. Anorg. Allg. Chem. 621:1995;229.
25. Lazarini F. Acta Crystallogr. B. 35:1979;448.
26. Sundvall B. Inorg. Chem. 22:1983;1906.
27. Shen L.L., Mischer L.A., Sharma P.N., O'Donell T.J., Chu D.W.T., Cooper C.S., Rosen T., Pernet A.G. Biochemistry. 28:1989;3886.
28. Buckingham D.A., Clark C.R., Nangia A. Aust. J. Chem. 43:1990;301.
29. Lee D.S., Han H.J., Him K., Park W.B., Cho J.K., Kim J.H. J. Pharm. Biomed. Anal. 12:1994;157.
30. Turel I., Bukovec N., Farkas E. Polyhedron. 15:1996;269.
31. V. Lorian, Antibiotics in Laboratory Medicine, 3rd ed., Williams & Wilkins, Baltimore, MD, 1991, pp. 1077-1149.